Granisetron: is there a dose–response effect on nausea and vomiting? Masaru Minami Review 29 May 2003 Pages: 89 - 98
Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancer S. UrienP. FumoleauR. Deporte-Fety Original Article 27 May 2003 Pages: 99 - 107
Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics Vinicius de Lima VazquezO. Anthony StuartPaul H. Sugarbaker Original Article 21 May 2003 Pages: 108 - 112
A retrospective evaluation of the feasibility of intrapatient dose escalation as appropriate methodology for dose-ranging studies for combination cytotoxic regimens Sarah D. JordanChristopher J. PooleAndrea Burton Original Article 29 May 2003 Pages: 113 - 118
A phase I trial of weekly paclitaxel, 13-cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies A. ThalasilaElizabeth PoplinRobert S. DiPaola Original Article 24 May 2003 Pages: 119 - 124
Phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer Yasuhide YamadaKuniaki ShiraoAtsushi Ohtsu Original Article 29 May 2003 Pages: 125 - 130
Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies Daniela MecoTina ColomboRiccardo Riccardi Original Article 29 May 2003 Pages: 131 - 138
Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats Steven M. MusserMerrill J. EgorinJulie L. Eiseman Original Article 22 May 2003 Pages: 139 - 146
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study Michela DonadioMara ArdineOscar Bertetto Original Article 23 May 2003 Pages: 147 - 152
Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study Ross A. SooHong L. LimBoon C. Goh Original Article 16 May 2003 Pages: 153 - 158
Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assay Daniel L. GustafsonMichael E. LongS. Gail Eckhardt Original Article 21 May 2003 Pages: 159 - 166
Metabolism of dexrazoxane (ICRF-187) used as a rescue agent in cancer patients treated with high-dose etoposide Patricia E. SchroederPeter Buhl JensenBrian B. Hasinoff Original Article 15 May 2003 Pages: 167 - 174